Catheter-Related Infections Clinical Trial
Official title:
The Effectiveness of Chlorhexidine Gluconate Bathing on Prevention of Catheter-Related Bloodstream Infections in Pediatric Intensive Care Unit
Verified date | August 2023 |
Source | Istanbul Medeniyet University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Catheter-related bloodstream infections are associated with increased mortality, morbidity, and length of hospital stay. The incidence has decreased significantly with the strict implementation of preventive bundle cares and checklists in intensive care units. Bathing with solutions containing chlorhexidine has been included in preventive strategies in recent years. Although some studies have shown that chlorhexidine bathing reduces the frequency of hospital-associated infections, there are important differences in management of practice and adherence to practice in different facilities. The majority of the studies conducted include adult patients. According to the CDC guidelines, chlorhexidine bathing is recommended for children over 2 months of age to prevent catheter-related bloodstream infection. The aim of this study is to investigate the effect of daily bathing with 2% chlorhexidine gluconate solution in preventing catheter-related bloodstream infections in pediatric patients with temporary central venous catheters.
Status | Recruiting |
Enrollment | 200 |
Est. completion date | May 1, 2024 |
Est. primary completion date | May 1, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 2 Months to 18 Years |
Eligibility | Inclusion Criteria: - Patients between the ages of 2 months and 18 years who had a temporary central venous catheter - Patients whose follow-up is continued for at least 48 hours with a central venous catheter Exclusion Criteria: - Patients younger than 2 months of age - Patients with a intensive care unit stay shorter than 48 hours - Immunosuppressive patients - Patients with a history of allergic reaction to chlorhexidine - Patients with skin lesions that interfere with skin cleansing with chlorhexidine - Patients whose family did not give consent |
Country | Name | City | State |
---|---|---|---|
Turkey | IMU | Istanbul | Kadiköy |
Lead Sponsor | Collaborator |
---|---|
Istanbul Medeniyet University |
Turkey,
Tien KL, Sheng WH, Shieh SC, Hung YP, Tien HF, Chen YH, Chien LJ, Wang JT, Fang CT, Chen YC. Chlorhexidine Bathing to Prevent Central Line-Associated Bloodstream Infections in Hematology Units: A Prospective, Controlled Cohort Study. Clin Infect Dis. 2020 — View Citation
Zerr DM, Milstone AM, Dvorak CC, Adler AL, Chen L, Villaluna D, Dang H, Qin X, Addetia A, Yu LC, Conway Keller M, Esbenshade AJ, August KJ, Fisher BT, Sung L. Chlorhexidine gluconate bathing in children with cancer or those undergoing hematopoietic stem c — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Catheter-related blood stream infection rates | In patients with a central catheter for longer than 48 hours, the diagnosis of bloodstream infection will be recorded as laboratory-confirmed bloodstream infections according to CDC diagnostic criteria.
Microorganisms detected in cultures will be classified as gram-positive and gram-negative or fungal agents. Infection with the resistant microorganism will be compared with the control group. |
2 years. | |
Primary | Catheter colonization rates | Catheter colonization; be defined as bacterial growth of more than 15 colonies in the semiquantitative culture or 1000 colonies in the quantitative culture of the catheter segment or hub without clinical symptoms. | 2 years. | |
Primary | Demographic features of participants | The investigators will be evaluating the features below:
Age of the patients (months) Sex of patients Weight of patients (kilograms) Height of patiens (centimeters) |
2 years. | |
Primary | Comorbidities of participants | The investigators will be evaluating the comorbidities in each groups, in order to determine if any of these conditions would interfere with infection rates. | 2 years. | |
Primary | Catheter site of placement | It will be classified as; femoral, internal jugular, subclavian. | 2 years. | |
Primary | The duration of intensive care unit stay for each participants | It will be evaluated as days. | 2 years. | |
Primary | Duration of catheter usage | It will be evaluated as the total amount of time as days. | 2 years. | |
Primary | Number of catheter lumens | It will be evaluated wether it has 2 or 3 lumens. | 2 years. | |
Primary | Time when catheter is started the use | It will be noted that the time of intensive care hospitalization that catheter usage started.
It will be evaluated as days. |
2 years. | |
Primary | Number of catheter dressing changes | It will be evaluated that the amount of planned or unplanned changes of catheter dressing. | 2 years. | |
Primary | Reason for the catheter removal | It will be classified as for example; infection, dysfunction, lack of need... | 2 years. | |
Primary | The reason of intensive care hospitalization for each participants | It will be evaluated that the primary reason that cause for patient to need for intensive care. | 2 years. | |
Primary | PRISM (pediatric risk of mortality) score of the participants | The Pediatric Risk of Mortality (PRISM) score was developed from the Physiologic Stability Index (PSI) to reduce the number of physiologic variables required for pediatric ICU (PICU) mortality risk assessment and to obtain an objective weighting of the remaining variables. | 2 years. | |
Primary | Need for invasive mechanical ventilation support | It will be evaluated if the patient needed for invasive mechanical ventilation support or not. If so, how many days is it required will be noted. | 2 years. | |
Primary | Need for hemodialysis catheter usage | It will be noted that wether the patient has hemodialysis catheter or not. | 2 years. | |
Primary | Presence of parenteral steroid use | It will be noted that if during the intensive unit care, wether patient need pulse steroid treatment (30milligram/kilogram/day for 3 or more days) or treatment with Prednisolone 2 milligram/kilogram/day or more for 14 or more days | 2 years. | |
Secondary | Rate of catheter-related bloodstream infection in patients bathing with 2% chlorhexidine gluconate daily. | Incidence will be determined by dividing the number of patients who had catheter-related bloodstream infections in patients who underwent daily skin cleansing with chlorhexidine, compared to the total number of patients who underwent daily skin cleansing with chlorhexidine.
Patients who were treated with a standard bath and those treated with a chlorhexidine bath will be compared. |
Through study completion, 2 years. | |
Secondary | Rate of catheter colonization in patients bathing with 2% chlorhexidine gluconate daily. | Incidence will be determined by dividing the number of patients who had catheter colonization in patients who underwent daily skin cleansing with chlorhexidine, compared to the total number of patients who underwent daily skin cleansing with chlorhexidine.
Patients who were treated with a standard bath and those treated with a chlorhexidine bath will be compared. |
2 years. | |
Secondary | Microorganisms that grown in cultures of catheter-related bloodstream infection in patients bathing with 2% chlorhexidine gluconate daily. | It will be noted which microorganisms grown in the cultures. By classifying microorganisms grown in culture (gram positive, gram negative, fungal infections, etc.), a comparison will be made between the two groups in terms of incidence. | 2 years. | |
Secondary | Microorganisms that cause catheter colonization in patients bathing with 2% chlorhexidine gluconate daily. | It will also be noted which microorganisms grown in the cultures. By classifying microorganisms grown in culture (gram positive, gram negative, fungal infections, etc.), a comparison will be made between the two groups in terms of incidence. | 2 years. | |
Secondary | Rate of catheter-related bloodstream infection in patients who applied standard bathing | Incidence will be determined by dividing the number of patients who had catheter-related bloodstream infection in patients who underwent standard bathing to the total number of patients who underwent standard bathing.
Patients who were treated with a standard bath and those treated with a chlorhexidine bath will be compared. |
2 years | |
Secondary | Rate of catheter colonizsation in patients who applied standard bathing | Incidence will be determined by dividing the number of patients who had catheter colonization in patients who underwent standard bathing to the total number of patients who underwent standard bathing.
Patients who were treated with a standard bath and those treated with a chlorhexidine bath will be compared. |
2 years | |
Secondary | Microorganisms that grown in cultures of catheter-related bloodstream infection in patients which applied standard bathing | It will also be noted which microorganisms grown in the cultures. By classifying microorganisms grown in culture (gram positive, gram negative, fungal infections, etc.), a comparison will be made between the two groups in terms of incidence. | 2 years. | |
Secondary | Microorganisms that cause catheter colonization in patients which applied standard bathing | It will also be noted which microorganisms grown in the cultures. By classifying microorganisms grown in culture (gram positive, gram negative, fungal infections, etc.), a comparison will be made between the two groups in terms of incidence. | 2 years. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04787926 -
DuraLock-C Catheter Lock Solution
|
||
Active, not recruiting |
NCT02515201 -
Heparin Versus Taurolidine to Bloodstream Infection Prevention Related in Central Venous Catheter in Children
|
Phase 4 | |
Recruiting |
NCT04140916 -
Comparison of Two Peripheral Inserted Intravenous Catheters
|
N/A | |
Not yet recruiting |
NCT06019897 -
Impact of Tubing Colonization on the Incidence of Central Venous Catheter Infection
|
||
Completed |
NCT02970409 -
Heparin Versus Saline in Peripheral Venous Catheter
|
N/A | |
Completed |
NCT03101371 -
Reducing Urinary Tract Infection Rates Using a Controlled Aseptic Protocol for Catheter Insertion
|
Phase 2 | |
Completed |
NCT04821193 -
Comparison of the Effects of 5%NaHCO3, 2%CHG and 70%Alcohol in the Prevention of Infections Related to Catheter
|
N/A | |
Completed |
NCT04155723 -
Impact of a Task Delegation to ICU Nurses for Midlines' Placement
|
||
Completed |
NCT02577718 -
Safety and Effectiveness of Novel Nitroglycerin Based Catheter Lock Solution
|
Phase 1/Phase 2 | |
Completed |
NCT02279121 -
ATAPAC Study (TauroLock Activity in Adult Cancer Patients)
|
N/A | |
Completed |
NCT00965198 -
Comparison of Infection Rates Among Patients Using Two Catheter Access Devices
|
N/A | |
Recruiting |
NCT05741866 -
Novel Antimicrobial Dressing in Peripheral Intravenous Catheters (PIVCs)
|
N/A | |
Recruiting |
NCT04825314 -
Noble Meta Alloy Coated Catheters in Patients With Long Term Catheterization
|
N/A | |
Active, not recruiting |
NCT03945045 -
A Study of the IJV or the SCV Approach for Ultrasound-guided Implantation of TIVAD
|
N/A | |
Active, not recruiting |
NCT01592032 -
Concentration of Antimicrobials in Catheter-lock Solutions
|
Phase 4 | |
Terminated |
NCT04906512 -
Comparing CHG I.V. Securement Dressing With Transparent Dressing for Evaluation of Antimicrobial Efficacy
|
N/A | |
Withdrawn |
NCT02899780 -
Treatment of Infected Dialysis Catheters With Fiber Optic Ultraviolet Light
|
N/A | |
Completed |
NCT04794231 -
Comparison of Chlorhexidine Impregnated Dressing and Standard Dressing
|
N/A | |
Terminated |
NCT03447639 -
Betadine Bladder Irrigations vs. Standard of Care Prior to Indwelling Catheter Removal
|
Phase 4 | |
Completed |
NCT03950921 -
Pilot Testing a Patient Safety Display in the Hospital Setting
|
N/A |